https://www.selleckchem.com/products/mbx-8025.html
12, 95% confidence intervals 1.04-4.30; P = .04). HLA-A∗2402 may be a risk factor for LTG-cADRs. HLA-A∗2402 may be a risk factor for LTG-cADRs. To investigate whether MRI features could preoperatively predict local tumor progression (LTP) in patients with hepatocellular carcinoma (HCC) treated with radiofrequency ablation (RFA) as the first-line treatment and improve a novel predictive model through developing a nomogram including various conventional MRI parameters. 105 patients with HCCs who had received RFA were enrolled. All patien
Like
Comment
Share
